CJC-1295

Also known as: DAC-GRF

Limited Evidence

Classification

Peptide

Regulatory Status

Overview

CJC-1295 is represented by its commonly described ghrh analog mechanism. This conservative launch record supports search and overlap detection, not medical recommendation.

Evidence and limitations

Human/preclinical evidence breakdown is not available in this record.

ClassB-only source; regulated fields intentionally limited. | ClassB source cannot establish ClassA canonical truth; regulated fields blanked.

Pathways

GH-IGF-1 axispituitary-signalingGHRH analoggrowth-hormone-release

Benefits

Evidence reviewed for research reference; BioStack presents this as educational reference, not a recommendation.

Interactions & cautions

Flagged in source data

tesamorelin or other GH secretagogues

Drug interactions

other GH secretagogues — Potential additive or opposing effects may occur. (review)

These are observational flags for review, not individualized instructions.

Sources

https://pubchem.ncbi.nlm.nih.gov/#query=CJC-1295 (opens in a new tab)

Educational reference only — not medical advice.